![Peter M. Chakoutis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Peter M.
Chakoutis served as the Chief Financial Officer at DUSA Pharmaceuticals, Inc. and as the Vice President-Finance at Harvard Apparatus Regenerative Technology, Inc. He also briefly served as the Chief Financial & Accounting Officer at Harvard Apparatus Regenerative Technology, Inc. Mr. Chakoutis holds an undergraduate degree from Norwich University and a graduate degree from Bentley Graduate School of Business.
Eerdere bekende functies van Peter M. Chakoutis
Bedrijven | Functie | Einde |
---|---|---|
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Financieel Directeur/CFO | 29-10-2020 |
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Financieel Directeur/CFO | 17-01-2020 |
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Financieel Directeur/CFO | 01-04-2005 |
Opleiding van Peter M. Chakoutis
Norwich University | Undergraduate Degree |
Bentley Graduate School of Business | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
DUSA Pharmaceuticals, Inc.
![]() DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA. | Health Technology |